A Prospective Study of Patient Reported Outcomes in Pancreatic and Peri‐ampullary Malignancy

Abstract

Pancreaticoduodenectomy has a short-term negative impact on PRO that recovers within 6 months and is maintained at 2 years in survivors. Further work evaluating palliative and curative treatment in larger patient groups with disease-specific questionnaires is necessary.